[go: up one dir, main page]

MXPA02012090A - Un metodo de tratamiento de corea de huntington con una proteina que se puede extraer de organos de mamifero. - Google Patents

Un metodo de tratamiento de corea de huntington con una proteina que se puede extraer de organos de mamifero.

Info

Publication number
MXPA02012090A
MXPA02012090A MXPA02012090A MXPA02012090A MXPA02012090A MX PA02012090 A MXPA02012090 A MX PA02012090A MX PA02012090 A MXPA02012090 A MX PA02012090A MX PA02012090 A MXPA02012090 A MX PA02012090A MX PA02012090 A MXPA02012090 A MX PA02012090A
Authority
MX
Mexico
Prior art keywords
chorea
huntington
treatment
mammalian organs
protein extractable
Prior art date
Application number
MXPA02012090A
Other languages
English (en)
Inventor
Alberto Panerai
Original Assignee
Rakepoll Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakepoll Holding B V filed Critical Rakepoll Holding B V
Publication of MXPA02012090A publication Critical patent/MXPA02012090A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un metodo de tratamiento de pacientes afectados por corea de Huntington comprende la administracion de una cantidad efectiva de una proteina 14 kDa que se puede extraer de organos de mamifero, particularmente higado de mamifero.
MXPA02012090A 2000-06-08 2001-06-04 Un metodo de tratamiento de corea de huntington con una proteina que se puede extraer de organos de mamifero. MXPA02012090A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21000000P 2000-06-08 2000-06-08
PCT/EP2001/006338 WO2001093895A2 (en) 2000-06-08 2001-06-04 A method of treatment of huntington's chorea with a protein extractable from mammalian organs

Publications (1)

Publication Number Publication Date
MXPA02012090A true MXPA02012090A (es) 2004-08-19

Family

ID=22781204

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012090A MXPA02012090A (es) 2000-06-08 2001-06-04 Un metodo de tratamiento de corea de huntington con una proteina que se puede extraer de organos de mamifero.

Country Status (7)

Country Link
US (1) US20030153511A1 (es)
EP (1) EP1286687A2 (es)
JP (1) JP2003535142A (es)
AU (1) AU2001272453A1 (es)
CA (1) CA2411429A1 (es)
MX (1) MXPA02012090A (es)
WO (1) WO2001093895A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche

Also Published As

Publication number Publication date
WO2001093895A3 (en) 2002-10-31
JP2003535142A (ja) 2003-11-25
US20030153511A1 (en) 2003-08-14
CA2411429A1 (en) 2001-12-13
WO2001093895A2 (en) 2001-12-13
EP1286687A2 (en) 2003-03-05
AU2001272453A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
MXPA03004793A (es) Roedores transgenicos transcromosomales para elaborar anticuerpos humnanos.
PT738128E (pt) Sistema para inserir material no estroma da cornea
PT1324776E (pt) Formulações de proteína concentradas de viscosidade reduzida
WO2001098331A3 (en) Glucagon-like peptide-1 analogs
WO2004066805A3 (en) In vivo device for improving diastolic ventricular function
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
WO1999060987A3 (en) Control of pain with endogenous cannabinoids
WO2000066528A3 (en) Quinones for treatment of diseases
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
MXPA03005922A (es) Metodo para tratar glaucoma ib.
WO2000071716A3 (en) Vascular endothelial growth factor dimers
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
MXPA02012089A (es) Metodo de tratamiento de la enfermedad de alzheimer con una proteina extraible de organos mamiferos.
MXPA02012090A (es) Un metodo de tratamiento de corea de huntington con una proteina que se puede extraer de organos de mamifero.
EP1121932A4 (en) MEDICINE FOR EYE DISEASES
IL131478A0 (en) Methods for treatment of scar tissue
MXPA02012091A (es) Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.
WO2003059387A3 (en) Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
MXPA02012092A (es) Metodo de tratamiento de la enfermedad de parkinson con una proteina extraible de organos.
DE60123105D1 (de) Verfahren zur Herstellung von 4'-O-substituierten 4'-Demethyl-1 desoxypodophyllotoxinderivaten und geometrischen Isomeren davon ,und Antikrebspräparat, das diese enthält
DE69930419D1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
ZA981558B (en) Inclusion complexes in aqueous solution
AU2001268461A1 (en) Uncoupling proteins as targets for the treatment of heart failure
UA33230A (uk) Спосіб підготовки кишечнику до операції
HU0203956D0 (en) Process for the preparation of linear or branched 1,4-cis polybutadiene